[Total body irradiation in hematology: clinical indications and prospects].
Corvò
R
R
D000293:Adolescent; D000328:Adult; D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D002066:Busulfan / Q000008:administration & dosage; D002648:Child; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D006801:Humans; D007938:Leukemia / Q000188:drug therapy / Q000532:radiotherapy* / Q000628:therapy; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000532:radiotherapy; D008223:Lymphoma / Q000188:drug therapy / Q000532:radiotherapy* / Q000628:therapy; D008232:Lymphoproliferative Disorders / Q000188:drug therapy / Q000532:radiotherapy* / Q000628:therapy; D011879:Radiotherapy Dosage; D013997:Time Factors; D014019:Tissue Donors; D014916:Whole-Body Irradiation / Q000009:adverse effects
D018906:Antineoplastic Agents, Alkylating; D003520:Cyclophosphamide; D002066:Busulfan